Shares of the fifth largest pharmaceutical company in the Indian market with a dominant position in the therapy areas of anti-infectives, gastrointestinal, pain management drugs and supplements are in focus on Monday, after SBI Mutual Fund bought shares worth a total...
A major stakeholder has offloaded a sizable portion of its shares in a leading pharmaceutical company. The transaction involved the sale of a 0.82% stake at an average price of Rs 5,468.99 per share, totalling a substantial Rs 541.16 crore. This bulk deal has been...
Search Topic or Keyword
Easiest Stock Screener Tool!
Best stock discovery tool with +130 filters, built for fundamental analysis. Profitability, Growth, Valuation, Liquidity, and many more filters. Search Stocks Industry-wise, Export Data For Offline Analysis, Customizable Filters.
